HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laurent Peyrin-Biroulet Selected Research

Crohn Disease (Crohn's Disease)

11/2022IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: The PROCTRIAL Consensus.
10/2022CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease.
10/2022Prevalence of anti-TNF contraindications in Crohn's disease: A cross-sectional survey from the GETAID.
7/2022Comparative Acceptability of Therapeutic Maintenance Regimens in Patients With Inflammatory Bowel Disease: Results From the Nationwide ACCEPT2 Study.
6/2022Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis.
5/2022Early Biological Therapy in Operated Crohn's Disease Patients Is Associated With a Lower Rate of Endoscopic Recurrence and Improved Long-term Outcomes: A Single-center Experience.
5/2022Ustekinumab in Crohn's Disease: New Data for Positioning in Treatment Algorithm.
2/2022JAK inhibitors in crohn's disease: ready to go?
1/2022Do JAK inhibitors have a realistic future in treating Crohn's disease?
1/2022Anti-TNF therapy for inflammatory bowel disease in patients with neurodegenerative Niemann-Pick disease Type C.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Laurent Peyrin-Biroulet Research Topics

Disease

159Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
12/2022 - 10/2006
155Crohn Disease (Crohn's Disease)
11/2022 - 09/2006
123Ulcerative Colitis
12/2022 - 04/2007
41Inflammation (Inflammations)
12/2022 - 10/2006
30Infections
11/2022 - 10/2006
29Necrosis
01/2022 - 07/2011
29Neoplasms (Cancer)
01/2022 - 12/2006
23Colitis
01/2021 - 04/2007
16Rheumatoid Arthritis
06/2022 - 07/2009
13Fistula
01/2022 - 09/2006
10Psoriasis (Pustulosis Palmaris et Plantaris)
02/2022 - 05/2015
9Pathologic Constriction (Stenosis)
01/2022 - 08/2010
9Hemorrhage
01/2022 - 01/2019
8Herpes Zoster
06/2022 - 08/2013
8Disease Progression
01/2022 - 01/2010
7Proctitis
11/2022 - 08/2008
7Fibrosis (Cirrhosis)
11/2022 - 03/2006
7COVID-19
06/2022 - 01/2020
6Anemia
10/2022 - 12/2015
6Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 07/2013
6Opportunistic Infections (Opportunistic Infection)
07/2021 - 09/2006
6Sclerosing Cholangitis
11/2020 - 11/2006
5Psoriatic Arthritis
02/2022 - 06/2017
5Abscess
01/2022 - 09/2012
5Multiple Sclerosis
01/2021 - 09/2006
4Iron Deficiencies
10/2022 - 02/2016
4Rheumatic Diseases (Rheumatism)
06/2022 - 06/2020
4Ankylosing Spondylitis
02/2022 - 01/2012
4Ulcer
01/2022 - 03/2015
4Skin Neoplasms (Skin Cancer)
12/2020 - 01/2014
4Carcinogenesis
12/2017 - 06/2004
3Abdominal Pain (Pain, Abdominal)
10/2022 - 01/2022
3Thrombosis (Thrombus)
06/2022 - 05/2007
3Chronic Renal Insufficiency
02/2022 - 12/2015
3Dysbiosis
01/2022 - 12/2017
3Arthralgia (Joint Pain)
01/2022 - 12/2019
3Pyoderma Gangrenosum
07/2021 - 01/2012
3Uveitis
01/2021 - 01/2012

Drug/Important Bio-Agent (IBA)

63Infliximab (Remicade)FDA Link
06/2022 - 11/2006
41Biological ProductsIBA
01/2022 - 03/2006
35Adalimumab (Humira)FDA Link
01/2022 - 04/2007
32Pharmaceutical PreparationsIBA
12/2022 - 01/2012
31vedolizumabIBA
12/2022 - 02/2014
31Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 06/2008
21tofacitinibIBA
01/2022 - 05/2013
20Ustekinumab (CNTO 1275)FDA Link
12/2022 - 03/2015
19Biosimilar PharmaceuticalsIBA
01/2021 - 01/2015
18Leukocyte L1 Antigen Complex (Calgranulin)IBA
10/2022 - 09/2013
16Tumor Necrosis Factor InhibitorsIBA
01/2022 - 06/2008
16SteroidsIBA
01/2022 - 06/2011
15C-Reactive ProteinIBA
12/2022 - 12/2010
15Biomarkers (Surrogate Marker)IBA
11/2022 - 01/2014
15Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 02/2010
14Mesalamine (Mesalazine)FDA LinkGeneric
01/2021 - 01/2013
13Azathioprine (Imuran)FDA LinkGeneric
07/2022 - 12/2008
13Immunologic Factors (Immunomodulators)IBA
01/2021 - 02/2010
12Immunosuppressive Agents (Immunosuppressants)IBA
01/2022 - 07/2013
12Monoclonal AntibodiesIBA
01/2022 - 01/2011
122-mercaptopurineIBA
12/2020 - 06/2011
11CytokinesIBA
10/2022 - 02/2011
11Janus Kinase InhibitorsIBA
06/2022 - 11/2013
9Phenobarbital (Luminal)FDA Link
11/2018 - 06/2008
8Folic Acid (Vitamin M)FDA LinkGeneric
10/2020 - 06/2004
7VaccinesIBA
01/2022 - 04/2011
7AntibodiesIBA
01/2022 - 08/2013
7Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
10/2020 - 05/2007
6Budesonide (Pulmicort)FDA LinkGeneric
12/2022 - 02/2014
6IronIBA
10/2022 - 12/2015
6Capsules (Microcapsules)IBA
09/2021 - 06/2005
6golimumabFDA Link
01/2021 - 02/2014
5Transferrin (beta 2 Transferrin)IBA
10/2022 - 02/2016
5Ferritins (Ferritin)IBA
10/2022 - 02/2016
5IntegrinsIBA
07/2022 - 11/2016
5InterleukinsIBA
07/2022 - 01/2020
5Janus KinasesIBA
06/2022 - 11/2013
5upadacitinibIBA
01/2022 - 01/2020
5NucleotidesIBA
07/2021 - 12/2008
5etrasimodIBA
06/2021 - 05/2017
5Dextrans (Dextran)FDA Link
10/2020 - 11/2011
5Thioguanine (Tioguanine)FDA Link
07/2020 - 12/2008
4Interleukin-23 (Interleukin 23)IBA
11/2022 - 01/2019
4Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric
08/2022 - 08/2009
4GLPG0634IBA
06/2022 - 08/2017
4Interleukin-17 (Interleukin 17)IBA
02/2022 - 01/2019
4sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
01/2021 - 05/2017
4Proteins (Proteins, Gene)FDA Link
11/2019 - 06/2011
4Methotrexate (Mexate)FDA LinkGeneric
03/2018 - 12/2010
4HomocysteineIBA
08/2008 - 05/2007
3CT-P13IBA
01/2022 - 01/2018
3Janus Kinase 1IBA
01/2021 - 01/2020
3sodium sulfate (sodium bisulfate)FDA LinkGeneric
10/2020 - 01/2017
3Interleukin-12 (IL 12)IBA
01/2020 - 01/2019

Therapy/Procedure

145Therapeutics
12/2022 - 11/2006
21Biological Therapy
12/2022 - 04/2011
15Colectomy
11/2022 - 02/2008
5Remission Induction
01/2022 - 07/2015
4Aftercare (After-Treatment)
11/2020 - 01/2019
3Restorative Proctocolectomy
11/2022 - 03/2018
3Ileostomy
11/2022 - 01/2012
3Precision Medicine
12/2021 - 01/2018